{Tris[2-(1H-imidazol-2-ylmethyleneamino-κ2N,N′)ethyl]amine}cobalt(II) bis(perchlorate) hemihydrateIn the title compound, [Co(C18H23N10)2](ClO4)2·0.5H2O, the CoII ion is coordinated by six N atoms from the tripodal organic ligand in a distorted square-bipyramidal geometry. There ...
Q. Crystal structure of [cinnamato-[tris(1-methylbenzimidazol-2-ylmethyl)-amine]-zinc(II)] perchlorate-dimethylformamide-methanol (1:1:2:0.5), [Zn(C27H27N7)(C9H7O2)](ClO4).2(CH3)2NCHO·0.5CH3OH. Z. Kristallogr. N. Cryst. Struct. 2008, 223, 152–154; https://doi.org/10.1524/...
查看详情 944561-44-8,Propargyl-PEG2-amine可以用于合成聚合物 面议 查看详情 1621616-14-5,Methylamino-PEG4-t-butyl ester 面议 查看详情 环糊精修饰的葡聚糖,Dextran-Cyclodextrin可以用于酶固定化 面议 查看详情 149577-05-9,m-PEG2-COOH是一种长链分子 面议 查看详情 115853-74-2,DMAE-NHS,具有低...
In the crystal, adjacent mol-ecules are linked into chains via pairs of O-H⋯O and N-H⋯O hydrogen bonds between the carboxyl-ate acceptor and the coordinated water and amine NH2 donors. Mol-ecules are further stacked by π-π inter-actions involving the benzene ring of the itp2-...
Crystal structure of {tris((1H-benzo[d]imidazol-2- yl)methyl)amine-κ4N,N′,N′′,N′′′}-(succinato-κ2O,O′)nickel(II) – methanol (1/4), C32H41N7NiO8C 32 H 41 N 7 NiO 8 , monoclinic, P 2 1 / c (no. 14), a = 10.0076(5) , b = 18.6561(10) , c = 19.0893...
Quiroz-Castro E,Bernès S,Barba-Behrens N.Structural and spectroscopic characterisation of tris(2-benzimidazolylmethyl)amine coordination compounds of Zn(Ⅱ),Cd(Ⅱ)and Hg(Ⅱ). Polyhedron . 2000Quiroz-Castro E,Bernès S,Barba-Behrens N.Structural and spectroscopic characterisation of tris(2-...
Crystal structure of N,N,N-tris[2-(2-nitro-1H-imidazol-1-yl)ethyl]amine, C15H18N10O6C15H18N10O6, monoclinic, P1211 (no. 4), a = 7.6597(8) , b = 12.422(1) , c= 10.084(1) , β= 99.996(9)°, V= 945.0 3, Z = 2, Rgt(F) = 0.031, wRref(F2) = 0....
Crystal structure of dinitrato-O-bis(tris((1H-benzo[d]imidazol-2-yl)methyl)amine-4N,N,N,N)-(2-cyclohexane-1,4-dicarboxylato-4O,O:O,O)dimanganese(II) C methanol C water (1/6/2), C62H80Mn2N16O18.doi:10.1515/ncrs-2017-0029C62H80Mn2N16O18, triclinic, P1? (no. 2...